Host genetics contributes to the effectiveness of dendritic cell-based HIV immunotherapy-Reference-Cited by-同舟云学术

Host genetics contributes to the effectiveness of dendritic cell-based HIV immunotherapy

Published:2018-05-17 Issue:8 Volume:14 Page:1995-2002
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Reis Edione C.¹,da Silva Lais T.²,da Silva Wanessa C.²,Rios Alexandre¹,Duarte Alberto J.²,Oshiro Telma M.²,Crovella Sergio³,Pontillo Alessandra¹

Affiliation:

1. Laboratório de Imunogenética, Departamento de Imunologia, Instituto de Ciências Biomédicas/ICB, Universidade de São Paulo/USP, São Paulo, SP, Brazil

2. Laboratório de Investigação Médica LIM-56, Departamento de Dermatologia, Faculdade de Medicina, Universidade de São Paulo/USP, São Paulo, SP, Brazil

3. Departamento de Genética, Universidade Federal de Pernambuco, Recife, PE, Brazil

Funder

the São Paulo Research foundation (FAPESP)

Brazilian National Council for Research (CNPq)

MCT/CNPq/MEC/CAPES Casadinho/Procad

E.C.R. is recipient of a Fellowship from FAPESP. A.P. and S.C. are recipient of a Fellowship from CNPq

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2018.1463942